From: Frogger on
More research, more studies, more tests...

Saw this online on Wired Science, the link goes to a site that has a
list of cities where participants are being recruited for a
"Randomized, Double Blind (Subject, Investigator), Placebo Control,
Parallel Assignment, Safety/Efficacy Study"

http://blog.wired.com/wiredscience/2008/04/drug-companies.html

Merck developed a new Hepatitis C medication which may make painful
interferon treatments unnecessary. It works by gumming up a protease,
which the virus uses to activate some of its building blocks by
separating them from one another. The same strategy has been used to
fight HIV for years, but every subtype of virus has a slightly
different enzyme, so each requires a unique drug.

Link: http://clinicaltrials.gov/ct2/show/NCT00518622?term=MK-7009&rank=1
From: Cactus Jammies on
very interesting. i wonder when some of these potential novel treatments
are going to be given the fast track for those of us who are getting along
in years?
cactus jammies
"Frogger" <soapwaffle(a)gmail.com> wrote in message
news:252da45f-4f40-432d-a1c4-3e54f9875bdf(a)a23g2000hsc.googlegroups.com...
> More research, more studies, more tests...
>
> Saw this online on Wired Science, the link goes to a site that has a
> list of cities where participants are being recruited for a
> "Randomized, Double Blind (Subject, Investigator), Placebo Control,
> Parallel Assignment, Safety/Efficacy Study"
>
> http://blog.wired.com/wiredscience/2008/04/drug-companies.html
>
> Merck developed a new Hepatitis C medication which may make painful
> interferon treatments unnecessary. It works by gumming up a protease,
> which the virus uses to activate some of its building blocks by
> separating them from one another. The same strategy has been used to
> fight HIV for years, but every subtype of virus has a slightly
> different enzyme, so each requires a unique drug.
>
> Link: http://clinicaltrials.gov/ct2/show/NCT00518622?term=MK-7009&rank=1
>